Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Background . Atherothrombotic disease, including coronary artery disease (CAD) and peripheral artery disease (PAD), can lead to cardiovascular (CV) events, such as myocardial infarction, stroke, limb ischemia, heart failure, and CV death. Aim . Evaluate the humanistic and economic burden of CAD and PAD and identify unmet needs through a comprehensive literature review. Methods . Relevant search terms were applied across online publication databases. Studies published between January 2010 and August 2017 meeting the inclusion/exclusion criteria were selected; guidelines were also included. Two rounds of screening were applied to select studies of relevance. Results . Worldwide data showed approximately 5–8% prevalence of CAD and 10–20% prevalence of PAD, dependent on the study design, average age, gender, and geographical location. Data from the REACH registry indicated that 18–35% of patients with CAD and 46–68% of patients with PAD had disease in one or more vascular beds. Use of medication to control modifiable CV risk factors was variable by country (lower in France than in Canada); statins and aspirin were the most widely used therapies in patients with chronic disease. Survival rates have improved with medical advancements, but there is an additional need to improve the humanistic burden of disease (i.e., associated disability and quality of life). The economic burden of atherothrombotic disease is high and expected to increase with increased survival and the aging population. Conclusion . CAD and PAD represent a substantial humanistic and economic burden worldwide, highlighting a need for new interventions to reduce the incidence of atherothrombotic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Baseline characteristics and medication use and clinical outcomes in patients with CAD and PAD from the REACH Registries of (a) Canada,a (b) France,b and (c) Germanyc [1, 2]. aPatients enrolled from January to October 2004; mean age 68.4 ± 9.9. bPercentage of patients experiencing at least one CV event (Figure (a): CAD n = 1356, PAD n = 146; Figure (b): CAD n = 2397, PAD n = 882; Figure (c): CAD n = 3328, PAD n = 1303). cPatients enrolled from December 2003 to June 2014; mean age 69.1–71.7 across risk groups. dPatients enrolled from December 2003 to June 2014; mean age 68.0–69.4 across risk groups. ACE, angiotensin-converting enzyme; ASA, acetylsalicylic acid; CAD, coronary artery disease; CV, cardiovascular; PAD, peripheral artery disease.](https://figures.cochat.ai/paper-figures/5e14fc8ebda846379e697620627d3268/burden-of-coronary-artery-disease-and-peripheral-artery-disease-a-literature-figure-1.jpg)
![Figure 2 The persistent risk of MACE (a) up to 3 years following an index MI (adapted from Blin et al., 2016) [3] and (b) up to 4.5 years following an index MI stratified by age (<72 years old versus ≥72 years old) and risk category (low versus higha) (adapted from Jernberg et al., 2015) [4]. aHigh-risk patients were predefined as those with ≥1 of the following risk factors prior to index; MI: diabetes mellitus, at least one MI prior to index MI event, CABG (proxy for multi-vessel CAD), PAD, stroke, heart failure, or diagnosis of chronic renal dysfunction. CABG, coronary artery bypass graft; CAD, coronary artery disease; CV, cardiovascular; HR, high risk; LR, low risk; MACE, major adverse cardiovascular events; MI, myocardial infarction; PAD, peripheral artery disease.](https://figures.cochat.ai/paper-figures/ef7f32f05aeb4415a5daae684132145b/burden-of-coronary-artery-disease-and-peripheral-artery-disease-a-literature-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mere presence of PAD significantly increases the risk of having atherosclerotic disease in other vascular beds.”
From Racial and Ethnic Disparities in Peripheral Artery Disease (2021) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Approximately, 46% to 68% of patients with PAD also had coronary artery disease (CAD) or cerebrovascular disease.[48][49][50]”
From Racial and Ethnic Disparities in Peripheral Artery Disease (2021) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.037 · Cited by 8,191 · cited 1×
“These conditions are characterized by progressive (CLI) or sudden onset (ALI) of pain at rest or nonhealing ischemic wounds or gangrene [27, 44, 45] and can ultimately lead to a loss of limbs [46].”
Background2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Aboyans, V., Ricco, J.-B., Bartelink, M.-L. E. L., Björck, M., Brodmann, M., Cohnert, T., Collet, J.-P., Czerny, M., De Carlo, M., Debus, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx095 · Cited by 3,293
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,410
Hay, S. I., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32130-x · Cited by 2,083 · cited 1×
“of mortality and morbidity worldwide, atherothrombotic disease places a substantial medical and economic burden on society [7, 12].”
Background2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.007 · Cited by 1,941
Research works printed but not linked: 1
- Gowdak L. H. W. Prevalence of refractory angina in clinical practice Heart and Metabolism 2017 72 9 12 2-s2.0-85018667587
Cited by
Items 401–482 of 482
Hubungan durasi tidur dan penyakit jantung koroner pada pria usia 40 tahun ke atas
Setyawan, Y. (2025) · HOLISTIK JURNAL KESEHATAN · doi:10.33024/hjk.v19i1.801
The VaSecure Paclitaxel Drug Coated Balloon Clinical Trial: One Year Outcomes
Shu, C., Li, X., Luo, M., Li, L., Li, X., Zhu, Y., Guo, X., Wang, H., Zhang, X., Zhai, S., et al. (2025) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2025.04.018
Yılmaz, T., & Özbey, F. (2025) · Balıkesır Health Sciences Journal · doi:10.53424/balikesirsbd.1541800
Enciu, A. (2025) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.91226
Espinola–Klein, C. (2025) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-2359-4339
Terle, P. M., & Bordes, S. J. (2025) · Springer eBooks · doi:10.1007/978-3-031-78326-5_111
Oral Anticoagulant Management for Peripheral Vascular Disease
Mulaney, B., & Dua, A. (2025) · Advances in Surgery · doi:10.1016/j.yasu.2025.05.003
Choopani, B., Shahouzehi, B., Ghafari, M., Shakeri, A., & Fallah, H. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104211
Aydın, G., & Kanan, N. (2025) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2025.06.004
Abdelrasol, A. (2024) · Tobruk University Journal of Medical Sciences · doi:10.64516/45h53e04 · Cited by 1
Danish, S., & Bill, T. (2025) · Journal of Cardiovascular Diseases · doi:10.52338/jocd.2025.4960
Zhang, W., Wang, H., Li, P., Wu, B., & Wang, X. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1542942
Koroner Arter Hastalıklarının Yönetiminde Sanal Gerçeklik Uygulamaları
Çiloğlu, Ş., Yaylaci, S., Paçacı, A. B., & Pirinççi, C. Ş. (2025) · KTO Karatay Üniversitesi Sağlık Bilimleri Dergisi · doi:10.59244/ktokusbd.1725718
Tarcisia, T., Siswoto, K. P. D., & Wahyuni, O. D. (2025) · Jurnal Kesehatan Tambusai · doi:10.31004/jkt.v6i2.44202
Spiridonov, A. N., Иванощук, Д. Е., Kashtanova, E. V., & Шахтшнейдер, Е. В. (2025) · Ateroscleroz · doi:10.52727/2078-256x-2025-21-3-237-247
Liu, Z., Ding, W., Ma, Z.-P., Zhang, T., & Zhao, Y. (2025) · BMC Medical Imaging · doi:10.1186/s12880-025-01966-w
“Coronary artery disease (CAD) continues to have a high death rate, causing a worldwide burden on economies and humanity [1].”
Circular RNA hsa_circ_0124644 regulates apoptosis of endothelial cells in coronary artery disease
Cui, Y., Zhao, B., Wang, S., Gui, L., Xiang, Y., Zhang, Z., Sun, X., Fan, J., Liu, J., & Huang, L. (2025) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-025-01123-1
“Atherosclerosis is an inflammatory condition that results in endothelial cell injury (Bauersachs et al. 2019), dysfunction, and apoptosis, all of which are important for CAD pathogenesis and its initial stages (Koyama et al. 2015).”
Zorlu, Ç., Demirezen, Y., Karaman, K., Karayakalı, M., & Çelik, A. (2025) · Angiology · doi:10.1177/00033197251382399
Li, M., Ma, X., Hu, J., Yang, R., Li, Z., & ShaMa, A. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04940-0
“The major alleles of ApoE gene are ε3, ε4 and ε2, ε3 is the most common subtype of ApoE gene, whereas ε4 and ε2 are relatively low [6, 20].”
Ashour, L., Ababneh, M., Alfadel, I., Alowisat, L. E., Sharabi, A., Heramas, R., Al-Hawwari, M., Alburqan, J., Hammad, A. M., Mustafa, D., et al. (2025) · International Journal of Angiology · doi:10.1055/a-2740-8916
Anatomy Guided Coronary Artery Segmentation from CCTA Using Spatial Frequency Joint ModelingPreprint
Huang, H., Esposito, M., & Zhao, C. (2025) · arXiv (Cornell University) · doi:10.48550/arxiv.2512.12539
Gefäßmedizinische Rehabilitation bei Patienten mit peripher arterieller Verschlusskrankheit (pAVK)
Dörr, G. (2025) · Geriatrie up2date · doi:10.1055/a-2724-2131
“…als auch asymptomatische Patienten mit einem ABI 0,9 gegenüber Patienten mit einem normalen ABI eine deutlich höhere Rate an schweren vas-kulären Ereignissen (Myokardinfarkt, koronare Revaskula-risation, Schlaganfall, Karotisrevaskularisation oder peri-phere vaskuläre Ereignisse der unteren…”
Borrowman, J. D. (2025) · Iowa Research Online (The University of Iowa) · doi:10.25820/etd.007506
Guo, N., Zhou, H., Zhang, Q., Fu, Y., Jia, Q., Gan, X., Wang, Y., He, S., Li, C., Tao, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25059422
Zhong, Q., Jin, S., Zhang, Z., Qian, H., Xie, Y., Yan, P., He, W., & Zhang, L. (2024) · Figshare · doi:10.6084/m9.figshare.26047008
Long, C. A., Williams, A. O., McGovern, A. M., Jacobsen, C. M., Hargens, L. M., Duval, S., & Jaff, M. R. (2024) · Figshare · doi:10.6084/m9.figshare.25216902
Pelletier‐Galarneau, M., Vandenbroucke, E., Lu, M., & Li, O. (2023) · Figshare · doi:10.6084/m9.figshare.22826781
Jalali, A., Hassanzadeh, A., Najafi, M. S., Nayebirad, S., Dashtkoohi, M., Karimi, Z., & Shafiee, A. (2024) · Figshare · doi:10.6084/m9.figshare.25596353
Zhong, Q., Jin, S., Zhang, Z., Qian, H., Xie, Y., Yan, P., He, W., & Zhang, L. (2024) · Figshare · doi:10.6084/m9.figshare.26047067
Jalali, A., Hassanzadeh, A., Najafi, M. S., Nayebirad, S., Dashtkoohi, M., Karimi, Z., & Shafiee, A. (2024) · Figshare · doi:10.6084/m9.figshare.26705772
Jalali, A., Hassanzadeh, A., Najafi, M. S., Nayebirad, S., Dashtkoohi, M., Karimi, Z., & Shafiee, A. (2024) · Figshare · doi:10.6084/m9.figshare.25596560
3D printing technology in hybrid cardiac electrophysiology
Cappello, I. A. (2024) · VUBIR (Vrije Universiteit Brussel)
Prevalence of Peripheral Artery Disease Among Adults with Sepsis
Iyer, S. (2023) · D-Scholarship@Pitt (University of Pittsburgh)
Machado, I. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Medizinische Rehabilitation bei Gefäßerkrankungen
Dörr, G., Marx, M., Prokein, R., Oettler, W., Severin, R., Nechwatal, R., & Meng, K. (2025) · Springer Reference Medizin · doi:10.1007/978-3-662-60880-7_182
Rahim, F., & Gozin, S. (2025) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.2025059978
Analytical and numerical modeling of fractional flow reserve in coronary arteries
Milovanović, A. (2024) · National Repository of Dissertations in Serbia
Reduced EEG complexity in stable coronary artery disease: an evidence of covert brain dysfunction
Huo, B., Wang, B., & Jia, H. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.061
Karenza, R. L., Paramadini, A. W., & Yusro, M. (2025) · Journal of Energy Mechanical Material and Manufacturing Engineering · doi:10.22219/jemmme.v10i1.40011
Mufarrih, S. H., Yunus, R. A., Sohail, M., Khan, M. S., Qureshi, N. Q., Saraswat, A., Hirsch, G. A., Tummala, S., Albaghdadi, M. S., & Tripathi, A. (2024) · Journal of Critical Limb Ischemia · doi:10.25270/jcli/clig23-00018
Haemodynamic impact of implant materials and anastomotic angle in femoro-popliteal artery grafts
Schoenborn, S., Lloyd, T., Sivakumaran, Y., Woodruff, M. A., Fletcher, D. F., Pirola, S., & Allenby, M. C. (2026) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-025-02037-3
“International research studies show a prevalence of approximately 10–20% for PAD depending on study design, country, and participant’s age and gender (Bauersachs et al. 2019).”
National epidemiological study of recently diagnosed patients with stable angina pectoris
Stojkovic, S. M., Rađen, G., Šekularac, N., Miladinovic, M., Viduljević, M., Isailović, N., & Dukić, Đ. (2024) · Srce i krvni sudovi · doi:10.5937/siks2403073s
Jabbari, M., Mortezazadeh, T., Motamedi, A., Samadi, S., Rezaei, S., & Gharepapagh, E. (2026) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.125.271265
Zhang, L., Guo, P., Qiu, J., Li, M., He, H., Li, Q., Liu, D., Shu, C., & Li, X. (2026) · Journal of Endovascular Therapy · doi:10.1177/15266028261418619
Wei, X., Yang, Z., Chen, M., Lu, H., & Hou, S. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1723015
PAD and Risk Factors: Systematic Review with ☸️SAIMSARA
SAIMSARA (2026) · SAIMSARA Journal · doi:10.62487/saimsarac805251e
Gabriele, O. (2026) · Research Publications (Maastricht University) · doi:10.26481/dis.20260318go
Erdoğan, B., Kuraş, S., Yıılmaz, F., Hacimustafaoğlu, F., Pence, M. E., & Pençe, H. H. (2026) · Online Türk Sağlık Bilimleri Dergisi · doi:10.26453/otjhs.1812461
Bryce, A. H., Nimke, D., Young, C., Shao, Q., Rozario, N. L., Kamdar, P., Ivanova, J. I., Varghese, I., & Touya, M. (2026) · Cardio-Oncology · doi:10.1186/s40959-026-00465-3
“For the subgroup of patients without CVD, a greater proportion of ENZA-treated patients had diabetes with chronic complication, peripheral vascular disease, and renal disease at baseline, which are key cardiovascular risk factors [19, 20].”
Zhang, Z., Fang, Z., Zhao, S., Abdurahman, M., Zhao, G., Feng, R., Guo, Z., Yu, X., Hong, H., Geng, J., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3198-0
“The incidence of these ischemic diseases has been escalating annually with the rising survival rates and the aging of the general population, imposing a substantial burden on public health systems (Bauersachs et al., 2019).”
Guilleron, C. (2021) · theses.fr (ABES) · doi:10.70675/2332679ezd767z4f30z905fz3e0c618d5dde
Analysis and correction of OCT images for the control of robotic flexible endoscopes
Liao, G. (2023) · theses.fr (ABES) · doi:10.70675/50792004ze7a1z4de8z8d39z22d7de5d06e4
Koushki, M. S., Sohrabi, B., & Parizad, R. (2026) · PubMed Central · doi:10.22088/cjim.17.1.173
The Ankle-Brachial Index in acute myocardial infarction: a window into polyvascular disease?
Rahouma, M., & Nardin, M. (2026) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.26.06931-0
Yu, D., Yu, Y., Zhang, T., Huang, W., Liang, X., & Ruan, Z. (2026) · International Journal of Clinical Practice · doi:10.1155/ijcp/6665417
Shabil, M., Maheswari, E., & Verma, A. (2026) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580261463121
Denysov, S. Y., & Hupalo, Y. M. (2026) · Ukrainian journal of cardiovascular surgery · doi:10.63181/ujcvs.2026.34(2).75-81
Role of NLR and CK-MB as predictive biomarkers for PCI in suspected CAD patients at PAAMCC
Alruwaili, F. K. S., & Khan, J. (2026) · International Journal of ADVANCED AND APPLIED SCIENCES · doi:10.21833/ijaas.2026.06.015
“In recent years, the disease burden has increased dramatically in both developed and developing countries (Bauersachs et al., 2019).”
Lin, L., Xia, H., & Yang, L. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1689455
The epidemiology and incidence of peripheral arterial disease. Recent data
Τσαγγαλάς, Η. Κ. (2026) · University of Thessaly Institutional Repository (University of Thessaly)
Guo, H., Xia, C., Du, Y., Ji, L., Yang, X., & Liu, H. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1868542
Multiterritory Arterial Ultrasound before Coronary CT Angiography: A 2‐Step Triage Model
Artyszuk, Ł., Błażejowska, E., Danielecka, Z., Jurek, J., Olek, E., & Abramczyk, P. (2026) · Journal of Ultrasound in Medicine · doi:10.1002/jum.70378
Saidova, M. (2025) · Farmaciya (Pharmacy) · doi:10.29296/25419218-2026-05-10
Cao, S., Zhang, B., Li, P., Luo, J., Tan, S., Lu, C., Fang, Y., Yang, C., 陈作观, Li, Y., et al. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06621-y
Xie, C., Zhuang, H., Zhengquan, D., Zhou, Y., Liang, H., & Wang, B. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1921708
Bauer, J. (2026) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.37545
Recent progress in the biomarkers of peripheral artery disease
Chen, B.-W., Chen, W., Yu, X.-H., & Wang, G. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.122864
Miceli, G., Basso, M. G., Cuffaro, M., Marchese, A., & Tuttolomondo, A. (2026) · Medicina · doi:10.3390/medicina62101905
“This multi-bed atherosclerosis state increases the longitudinal risk of MACE exponentially rather than additively [9] worsened by the concealment of silent concurrent coronary artery disease hidden by physical limitations imposed by IC preventing exertional threshold required to trigger angina [10].”
Heart Failure and Coronary Herat Diseases: Nursing Interventions and Care Plans-An Updated Review
Shafeiy, A. M. A. (2024) · Review of Contemporary Philosophy
Zulfiayu, Z. (2024) · Hasanuddin University Repository
Aspirin Unveiled: Shielding Hearts from Coronary Artery Disease
Malik, A. B., Mir, M. A., Qadrie, Z., & Dar, M. A. (2023) · International Journal of Current Research in Physiology and Pharmacology (IJCRPP)
Tripathy, S., & Patel, M. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1817332
Ali, M. A., Nawaz, A., Sethi, F. A., Alam, U., Ali, F., Khalil, Z., Usama, M., Imran, J., Inam, A., Khan, K., et al. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001492
Genovese, E. A., Williams, A. O., Sato, R., McGovern, A. M., & Jaff, M. R. (2026) · Journal of Comparative Effectiveness Research · doi:10.57264/cer-2026-0126
Valle, C. D., Zuin, M., & Bilato, C. (2026) · European Journal of Clinical Investigation · doi:10.1111/eci.70267
“Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of morbidity and mortality worldwide [1–3] with dyslipidemia, particularly low-density lipoprotein cholesterol (LDL-C) [4] representing a major causal driver of atherosclerosis [5].”
Bone morphogenetic protein 12: a novel target for cardiovascular disease
Isaza, S. C., Hernández-García, M. Á., Fernández-García, C. E., Pérez-Utrera, C., Álvarez‐Rubal, M., Muñoz, J. M., Friera, A., García‐Monzón, C., Gómez‐Hernández, A., Landete, P., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00609-y
Jan, N. (2026) · Research Publications (Maastricht University) · doi:10.26481/dis.20261116jn
Self-care and cardiac anxiety in coronary heart patients
Dolar, G. M. (2025) · Marmara University Open Access System
Ghali, H., Tlili, M. A., Hraïech, A. E., Sahli, J., Bhiri, S., Layouni, S., Souda, H. B., Karray, M., Pavy, B., Cheikh, A. B., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0361814
Metadata
- Authors
- Bauersachs, R., Zeymer, U., Brière, J.-B., Marre, C., Bowrin, K., & Huelsebeck, M.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Klinikum Ludwigshafen (DE)
- Bayer (Germany) (DE)
- Creativ-Ceutical (France) (FR)
- Bayer (United Kingdom) (GB)
- Corresponding author
- Bauersachs, Rupert
- Venue
- Cardiovascular Therapeutics
- Publisher
- Wiley
- Published
- 2019-11-26
- Volume
- 2019
- Pages
- 1-9
- ISSN
- 1755-5914 (ISSN-L)
- 1755-5922
- PMC
- PMC7024142
- OpenAlex
- W2990657953
- Semantic Scholar
- 7306e92becdce616c64c569876ca723660f04cb3
- Cited by
- 449
- References
- 52
- Citations by year
- 2026: 39 · 2025: 80 · 2024: 118 · 2023: 102 · 2022: 64 · 2021: 38 · 2020: 8
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Cardiovascular Therapeutics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion, cc-by)
- Funders
- Bayer AG
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Keywords
- coronary artery disease, peripheral arterial disease, atherothrombosis, disease burden, economic burden, humanistic burden, prevalence, quality of life, disability, statins, aspirin, cardiovascular risk management, survival rate, population aging, unmet needs
- MeSH terms
- Aged, Coronary Artery Disease, Female, Health Services Needs and Demand, Humans, Male, Prognosis, Risk Factors, Global Health, Incidence, Prevalence, Health Care Costs, Cost of Illness, Peripheral Arterial Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.